Log In
BCIQ
Print this Print this
 

Dopamine D2 receptor

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Dopamine D2 receptor

BCIQ
Print ChartPrint this
Marketed, 17 Marketed, 1 Approved, 3 Phase III, 2 Phase III, 2 Phase II, 8 Phase II, 1 Phase II, 1 Phase I, 2 Preclinical, 7 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIApprovedMarketed
Endocrine / Metabolic

-

-

-

-

-

1

Gastrointestinal

-

-

1

2

-

-

Genitourinary

1

-

-

-

-

-

Inflammation

-

-

1

-

-

-

Neurology

7

2

8

2

3

17




 Products Targeting Dopamine D2 receptor
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

21

$1,819.0M

$934.0M

$465.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today